Keystone Resort Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

B Cell-T Cell Interactions (J6)

joint with the meeting on Molecular Approaches to Vaccines and Immune Monitoring (J5)

Scientific Organizers: Gabriel D. Victora and Carola G. Vinuesa


February 10—14, 2019

Keystone Resort, Keystone, Colorado, USA


Sponsored by BioLegend, Inc.


IT’S NOT TOO LATE TO SUBMIT YOUR ABSTRACT. Abstracts received can no longer be considered for oral short talks. Abstracts for poster display opportunities will be accepted until 6 weeks before meeting start date midnight MST.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.

DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: Oct 23, 2018 [details]
Discounted Abstract Deadline: Oct 23, 2018 [details]
Abstract Deadline: Nov 7, 2018 [details]
Discounted Registration Deadline: Dec 6, 2018 [details]

Click here to view Cancellation Policy

Submit an Abstract Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2019-J6 "B Cell-T Cell Interactions" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On October 23, 2018 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After October 23, 2018 until December 30, 2018 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
October 23, 2018 n/a
Discounted NON-STUDENT Registration
More details
Before and On December 6, 2018 845.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details
After December 6, 2018 1045.00 USD
Discounted STUDENT Registration
More details
Before and On December 6, 2018 620.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details
After December 6, 2018 820.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.




Discounted Abstract Deadline: October 23, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is November 7, 2018)

Global Health Travel Award Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: October 23, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: November 7, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is October 23, 2018)

Discounted Registration Deadline: December 6, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 845.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 620.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1045.00 USD*
Student Registration Fee: 820.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that some meeting participants have received calls and emails from a number of different housing services, including "Exhibitors Housing Services," “Expo Housing Services,” "Global Housing," etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling, without any actual knowledge to that effect, and pressure you into giving them your credit card number to make a lodging reservation with them.

We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report any calls or correspondence you might have received to Keystone Symposia and book only through lodging links in your Keystone Symposia account, an established travel agency or directly with the hotel(s) listed on our website.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 24 hr (international) time


The meeting will begin on Sunday, February 10 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, February 14 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, February 15 in order to fully experience the meeting.

SUNDAY, FEBRUARY 10

4:00—8:00 PM
Arrival and Registration

Longs Peak Foyer
6:00—8:00 PM
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Longs Peak Foyer

MONDAY, FEBRUARY 11

7:00—8:00 AM
Breakfast

Colorado Rockies Ballroom
8:00—9:00 AM
Welcome and Keynote Address (Joint)
Registered attendees can view abstracts starting on 01/10/2019

Columbine Ballroom
Antonio Lanzavecchia, Institute for Research in Biomedicine, Switzerland
The B Cell Immune Response to Infection and Vaccination

9:00—11:15 AM
Tfh Biology
Registered attendees can view abstracts starting on 01/10/2019

Quandary Peak
Carola G. Vinuesa, Australian National University, Australia
Human Tfh Biology

Coffee Break

Hai Qi, Tsinghua University, China
Guidance Cues for Tfh Cells

Shane Crotty, La Jolla Institute for Allergy and Immunology, USA
Tfh Cell and Germinal Center B Cell Responses in the Context of Vaccines

Short Talk(s) Chosen from Abstracts

9:00—11:45 AM
Targeting Appropriate Immune Responses for Structure-Based Design
Registered attendees can view abstracts starting on 01/10/2019

Grays/Longs Peak
Dennis R. Burton, The Scripps Research Institute, USA
From Antibody to Vaccine

Coffee Break

George Georgiou, University of Texas at Austin, USA
Molecular Definition of Protective Serum Responses from Vaccination and for Immune Monitoring

Peter D. Kwong, NIAID, National Institutes of Health, USA
Iterative Structure-Based Optimization of Antibody-Guided Vaccines

Evelien M. Bunnik, University of Texas Health Science Center at San Antonio, USA
Short Talk: Naturally Acquired Protective Humoral Immunity Against Malaria

Nisreen Mamdouh Ahmed Okba†, Erasmus MC, Netherlands
Short Talk: Antibody Responses as Blueprint for MERS-CoV Rational Vaccine Design

Andrew McGuire, Fred Hutchinson Cancer Research Center, USA
Short Talk: An Anti-gH/gL Antibody that Neutralizes Dual-Tropic Infection Defines a Site of Vulnerability on Epstein-Barr Virus

11:15 AM—5:00 PM
On Own for Lunch

11:15 AM—1:00 PM
Poster Setup

Colorado Rockies Ballroom
1:00—10:00 PM
Poster Viewing

Colorado Rockies Ballroom
2:30—4:30 PM
Workshop 1: B Cell Biology in T-Dependent Responses

Quandary Peak
Short Talks Chosen from Abstracts

2:30—4:30 PM
Workshop 1: Molecular Design of Vaccines 

Grays/Longs Peak
Guillaume B.E. Stewart-Jones†, National Institutes of Health, USA
Structure-Based Design of Nipah and Parainfluenza Virus F Glycoprotein Vaccines

Bruno Emanuel Correia, École Polytechnique Fédérale de Lausanne, Switzerland
Trivalent Epitope-Focused Vaccine Elicits RSV Neutralization in NHPs

Timothy Caradonna, Ragon Institute, USA
Molecular Grafting of a Complex Broadly Neutralizing Influenza Hemagglutinin Epitope

Syed M. Moin, National Institutes of Health, USA
A Bi-component Nanoparticle Presenting Group 1 and 2 Influenza Hemagglutinin Stem Trimers Confers Inter-group Heterosubtypic Protections

Seyhan Boyoglu-Barnum, National Institutes of Health, USA
Computationally Designed Nanoparticles Displaying Influenza Virus Hemagglutinins of Seasonal Vaccine Strains

Cara Chao, NIAID, USA
An Isopeptide-Linking Platform to Incorporate Trimeric Antigens Into Self-Assembling Nanoparticle Immunogens

Sean H. Kelly, Duke University, USA
Molecular Design of Mucus-Penetrating Nanovaccines Enables Sublingual Peptide Immunization

4:30—5:00 PM
Coffee Available

Longs Peak Foyer
5:00—7:00 PM
Regulation of the GC Response
Registered attendees can view abstracts starting on 01/10/2019

Quandary Peak
Andre Ballesteros-Tato, University of Alabama at Birmingham, USA
Regulation of IL-2 Responses in the GC

Michelle A. Linterman, Babraham Institute, UK
Ageing and the Germinal Centre Response

Di Yu, Australian National University, Australia
Follicular Cytotoxic T Cells: Friends or Foes?

Short Talk(s) Chosen from Abstracts

5:00—7:00 PM
Clinical Results from Molecular-Based Vaccines 
Registered attendees can view abstracts starting on 01/10/2019

Grays/Longs Peak
Sumana Chandramouli, GSK Vaccines, USA
A Structural Biology Approach to Developing an HCMV Vaccine

Amy S. Espeseth, Merck & Co., USA
mRNA Vaccines Expressing Forms of RSV-F Protein are Immunogenic and Protective in Preclinical Models of Respiratory Syncytial Virus Infection

Barney S. Graham, NIAID, National Institutes of Health, USA
Clinical Results from the Prefusion-Stabilized RSV F (DS-Cav1) Subunit Vaccine

Katherine Burgomaster, NIH, USA
Short Talk: Limited Cross-Reactive Antibody Responses Elicited by a ZIKV DNA Vaccine Candidate

Adrian V. S. Hill†, Jenner Institute, University of Oxford, UK
Short Talk: Enhanced Efficacy of Anti-Liver-Stage Vectored Vaccines using a Prime-Target Immunisation Approach

7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom
7:30—10:00 PM
Poster Session 1

Colorado Rockies Ballroom

TUESDAY, FEBRUARY 12

7:00—8:00 AM
Breakfast

Colorado Rockies Ballroom
8:00—9:00 AM
Keynote Address (Joint)
Registered attendees can view abstracts starting on 01/10/2019

Columbine Ballroom
Michel C. Nussenzweig, HHMI/Rockefeller University, USA
Antibody Responses and Antibodies

9:00—11:15 AM
Germinal Center Biology
Registered attendees can view abstracts starting on 01/10/2019

Quandary Peak
Gabriel D. Victora, Rockefeller University, USA
Clonal Dynamics of the Antibody Response

Coffee Break

Jason G. Cyster, HHMI/University of California, San Francisco, USA
Guidance Cues in the B Cell Response

Tomohiro Kurosaki, WPI Immunology Frontier Research Center, Osaka University, Japan
Memory Cell Differentiation in the Germinal Center

Short Talk(s) Chosen from Abstracts

9:00—11:45 AM
B Cell Ontogenies as Vaccine Templates
Registered attendees can view abstracts starting on 01/10/2019

Grays/Longs Peak
Lynn Morris, National Institute for Communicable Diseases, South Africa
V2-directed vaccine-like antibodies from HIV-1 infection mediate ADCC and block α4β7 interactions

Coffee Break

William Schief, IAVI and The Scripps Research Institute, USA
Germline-Targeting Vaccine Design

Frederick W. Alt, Boston Children's Hospital, USA
Mouse Models for Lineage-Based Vaccines

Maya Sangesland, Ragon Institute of MGH, MIT and Harvard, USA
Short Talk: Germline-Encoded Affinity Facilitates Vaccine-Amplification of Broadly Neutralizing Antibodies Against Influenza Virus

Andrew J. Borst, University of Washington, USA
Short Talk: Germline VRC01 Antibody Recognition of a Modified Clade C HIV-1 Envelope Trimer and a Glycosylated HIV-1 gp120 Core

Amelia Escolano, Rockefeller University, USA
Short Talk: Prime Immunization Expands Precursors of Anti HIV-1 Broadly Neutralizing Antibodies in Mice, Rabbits and Rhesus Macaques

11:15 AM—5:00 PM
On Own for Lunch

11:15 AM—1:00 PM
Poster Setup

Colorado Rockies Ballroom
1:00—10:00 PM
Poster Viewing

Colorado Rockies Ballroom
2:30—4:30 PM
Workshop 2: Tfh/Tfr Differentiation and Function

Quandary Peak
Short Talks Chosen from Abstracts

2:30—4:30 PM
Workshop 2: Antibody Characterization and B Cell Sequencing

Grays/Longs Peak
Kathryn Hastie†, The Scripps Research Institute, USA
Convergent Structures Reveal Key Residues to Enhance Potency and Breadth for Pan-Lassa Virus Neutralization

Jonathan McDaniel, University of Texas at Austin, USA
R21 Vaccine Elicits Near Germline Serum Antibodies that Potently Inhibit Malaria Infection

Lan Zhang, Merck, USA
Characterization of Potent RSV Neutralizing Antibodies Isolated from Human Memory B Cells and Identification of a Novel RSV/hMPV Cross-Neutralizing Epitope

Bharat Madan, University of Kansas, USA
In Vitro Evolution of a Vaccine-Elicited Antibody Identifies New Capabilities for Effective Fusion Peptide-Based HIV Neutralization

Lauren E. Gentles, University of Washington, USA
Complete antigenic mapping of an influenza A virus non-neutralizing antibody

Goran Bajic†, Harvard Medical School, USA
Autoreactivity Profiles Of Influenza Hemagglutinin Broadly Neutralizing Antibodies

Pablo Canales Herrerias, Institut Pasteur, France
Characterizing Autoantibody-Producing Cells in Thrombocytopenic Patients for Secretion Rate and Affinity for a Platelet Autoantigen

Karyn McFadden, Amgen, USA
Rapid Discovery of Functional Antibodies from Primary Cells using an Optofluidic Single-Cell Screening Platform

4:30—5:00 PM
Coffee Available

Longs Peak Foyer
5:00—7:00 PM
Programming T Cells to Help B Cells
Registered attendees can view abstracts starting on 01/10/2019

Quandary Peak
Virginia Pascual, Cornell University, USA
Extra-follicular Help in Human SLE

Casey T. Weaver, University of Alabama at Birmingham, USA
Programming the Early Bifurcation of Tfh and Non-Tfh Effector Responses

Philippa C. Marrack, HHMI/National Jewish Health, USA
Tfh Memory

Short Talk(s) Chosen from Abstracts

5:00—7:00 PM
Tackling Difficult Pathogens with Molecular-Based Vaccine Design 
Registered attendees can view abstracts starting on 01/10/2019

Grays/Longs Peak
Ian A. Wilson, The Scripps Research Institute, USA
Towards a Universal Influenza Virus Vaccine: Is it Better to Target the HA Head or Stem?

Sarah F. Andrews, National Institutes of Health, USA
Identifying Common Antibody Lineages to Evaluate Clinical Responses to Influenza Vaccination

Erica Ollmann Saphire, The Scripps Research Institute, USA
Vaccine Design from a Prefusion-Stabilized Lassa Virus Trimer Structure

Andrew Flyak†, Caltech, USA
Common Genetic Signatures in HCV bNAbs: Implications for Vaccine Design

Johannes P.M. Langedijk†, Janssen Vaccines and Prevention, Netherlands
Stabilization of Conserved Metastable Structural Elements in Class I Fusion Proteins for Optimal Vaccine Design

7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom
7:30—10:00 PM
Poster Session 2

Colorado Rockies Ballroom

WEDNESDAY, FEBRUARY 13

7:00—8:00 AM
Breakfast

Colorado Rockies Ballroom
8:00—9:30 AM
Keynote Session (Joint)
Registered attendees can view abstracts starting on 01/10/2019

Columbine Ballroom
Facundo D. Batista, Ragon Institute of MGH, MIT and Harvard, USA
Importance of B Cell-T Cell Interactions in Mouse Vaccine Models

Hedda Wardemann, German Cancer Research Center, Germany
Development and Clonal Evolution of Human Memory B Cell Antibody Responses

Coffee Break

9:50—11:15 AM
B Cell Responses in Infectious Disease
Registered attendees can view abstracts starting on 01/10/2019

Quandary Peak
Patrick C. Wilson, University of Chicago, USA
The B Cell Response to Influenza and Vaccination

Frances E. Lund, University of Alabama at Birmingham, USA
T Cell Dependent Memory B Cell Responses in Influenza Infection and Vaccination

Short Talk(s) Chosen from Abstracts

9:50—11:45 AM
Immune Monitoring of B Cell Responses
Registered attendees can view abstracts starting on 01/10/2019

Grays/Longs Peak
Michael Joseph Mina, Brigham and Women's Hospital, USA
Reading the Record of Immunity: Profiling the Anti-Virome Antibody Repertoire with Phage Display and Deep Neural Networks

Margaret Ellen Ackerman, Dartmouth College, USA
Measuring and Mining Serum Antibody Responses to Understand Protection from Infection

Gwo-Yu Chuang, NIAID, National Institutes of Health, USA
Short Talk: Delineating the Sequence Signature of a Multi-donor Class of Human Antibodies that Broadly Neutralizes Influenza Viruses for Immune Monitoring of Vaccination Studies

Colin Havenar-Daughton, La Jolla Institute for Immunology, USA
Short Talk: Longitudinally Tracked, Rapid, Robust Antigen-Specific Germinal Center Responses and Somatic Hypermutation in Non-Human Primates After a Single Nanoparticle Vaccine Immunization

David B. Weiner†, Wistar Institute, USA
Short Talk: Immunogenicity and Protection with A Low-Dose Intradermal Vaccine INO-4700 Against Middle East Respiratory Syndrome in Non-Human Primates

11:15 AM—5:00 PM
On Own for Lunch

11:15 AM—1:00 PM
Poster Setup

Colorado Rockies Ballroom
1:00—10:00 PM
Poster Viewing

Colorado Rockies Ballroom
2:30—4:30 PM
Workshop 3: B Cell-T Cell Interactions in Disease

Quandary Peak
Short Talks Chosen from Abstracts

2:30—4:30 PM
Workshop 3: Molecular Probing of the Elicited Vaccine Response

Grays/Longs Peak
Maryam Mukhamedova, NIAID, National Institutes of Health, USA
Characterization of RSV Antibody Repertoire to B Cells Elicited by Prefusion RSV F Subunit Protein (DS-Cav1)-Vaccinated Adult Volunteers

Raffaello Verardi†, NIH/NIAID, USA
Structural Studies of Human Norovirus Antibodies Isolated from Vaccines Reveal Basis for Broad Reactivity

Christopher Andrew Cottrell, The Scripps Research Institute, USA
Immunofocusing Antibody Responses to Target the HIV Env Fusion Peptide (FP) Epitope in Non-Human Primates (NHPs)

Zizhang Sheng, Columbia University, USA
Developmental Pathways for Vaccine-Induced Neutralizing Antibodies Targeting the HIV-1 Fusion Peptide Suggest a Low Barrier to Elicitation

Sid Chaudhury†, US Army Medical Research and Material Command, USA
Using Machine Learning Methods to Identify Correlates of Protection in B and T Cell Responses in the RTS,S/AS01B Malaria Vaccine Candidate

Rajagopal Murugan, German Cancer Research Institute, Germany
Maturation of the Memory B Cell Response to Plasmodium Falciparum Circumsporozoite Protein (PfCSP) through Clonal Selection, Not Affinity Maturation

Elisabetta Frigimelica, GSK Vaccines S.r.l., Italy
Characterization of the Human Antibody Repertoire Following Immunization with Meningococcus B Vaccine

Murillo Silva, MIT, USA
Saponin-MPLA Nanoparticulate Adjuvants Alter Lymph Flow and Enhance Early Antigen Acquisition by B Cells

4:30—5:00 PM
Coffee Available

Longs Peak Foyer
5:00—7:00 PM
Memory Humoral Responses
Registered attendees can view abstracts starting on 01/10/2019

Quandary Peak
Marc K. Jenkins, University of Minnesota Medical School, USA
Memory T and B Cell Responses

Mark J. Shlomchik, University of Pittsburgh School of Medicine, USA
Memory B Cell Subsets

Marion Pepper, University of Washington, USA
Memory B Cells in Plasmodium Infection

Short Talk(s) Chosen from Abstracts

5:00—7:00 PM
Optimizing Vaccine Responses
Registered attendees can view abstracts starting on 01/10/2019

Grays/Longs Peak
Neil P. King, University of Washington, USA
Atomic-Level Design to Increase the Magnitude of B Cell Responses

Günther Staffler, AFFiRiS AG, Austria
Towards a Heart Attack Vaccine: PCSK9 as a Immunogen

Pierre Bruhns, Institut Pasteur, France
Monitoring Plasmablast Responses at the Single Cell Level

Sonia M. Maciejewski†, National Institutes of Health, USA
Short Talk: Distinct Correlates of Protection Among Closely Related ZIKV DNA Vaccines Identify a Critical Role for Antibody Quality Following Vaccination

Kimberly M. Cirelli, La Jolla Institute for Allergy and Immunology, USA
Short Talk: Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance

7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom
7:30—10:00 PM
Poster Session 3

Colorado Rockies Ballroom

THURSDAY, FEBRUARY 14

7:00—8:00 AM
Breakfast

Colorado Rockies Ballroom
8:00—11:00 AM
Humoral Autoimmunity and Allergic Responses
Registered attendees can view abstracts starting on 01/10/2019

Quandary Peak
Rachel Ettinger, Viela Bio, USA
VIB4920, a Novel CD40L Antagonist, Decreased Disease Activity and Improved Biomarkers of Immune Activation in a Phase 1b, Proof-of-Concept Study in Rheumatoid Arthritis

Michael C. Carroll, Boston Children's Hospital, Harvard Medical School, USA
Epitope Spreading in Autoimmune Germinal Centers

Coffee Break

Maria A. Curotto de Lafaille, NYU School of Medicine, USA
Biology of IgE Affinity Maturation

Christopher C. Goodnow, Garvan Institute of Medical Research, Australia
Progression from benign to pathogenic autoantibody by somatic mutation in a rogue clone: single cell RNA & DNA sequencing

Short Talk(s) Chosen from Abstracts

8:00—11:30 AM
Vaccines: Better, Faster, and Less Expensive!
Registered attendees can view abstracts starting on 01/10/2019

Grays/Longs Peak
Rino Rappuoli, GlaxoSmithKline Vaccines, Italy
Developing Vaccines against Pandemics and for the Developing World

Laura M. Walker, Adimab, USA
Rapid Antibody Identification to Speed Pandemic Responses

Coffee Break

Brandon DeKosky, University of Kansas, USA
Paired Heavy-Light Chain Sequencing and Display for Immune Monitoring of Vaccination and Natural Infection

Julie Ledgerwood, NIAID, National Institutes of Health, USA
Immune Monitoring to Increase the Likelihood of Phase 2 Success

Ami Patel, Wistar Institute, USA
Short Talk: Infection to Protection: An In Vivo Approach for Rapid Delivery of DNA-Encoded Monoclonal Antibodies (DMAbs) Isolated Directly from Ebola Virus Disease Survivors and Other Infectious Diseases

Julia Lederhofer†, NIH/NIAID/VRC, USA
Short Talk: Augmented Immune Responses by Co-Immunization of Commercial Seasonal Influenza Vaccine and the HA Stem-Based Universal Influenza Vaccine Candidates

Daniel R. Ellis, University of Washington, USA
Short Talk: Co-display of Multiple Antigenic Variants on Computationally-Designed Protein Nanomaterials as a Versatile Vaccine Platform

11:00 AM—5:00 PM
On Own for Lunch

4:30—5:00 PM
Coffee Available

Longs Peak Foyer
5:00—6:45 PM
T-Dependent B Cell Differentiation
Registered attendees can view abstracts starting on 01/10/2019

Quandary Peak
Klaus Rajewsky, Max Delbrück Center for Molecular Medicine, Germany
Transcriptional Programming of GC B Cell Differentiation

Meinrad Busslinger, Research Institute of Molecular Pathology, Austria
Ikaros Prevents Autoimmunity by Promoting Anergy Induction and Restraining Toll-like Receptor Signaling in B cells

Robert Brink, Garvan Institute of Medical Research, Australia
Constant Region-Based Selection in the Germinal Center Reaction

Short Talk Chosen from Abstracts

5:00—6:45 PM
Reducing Vaccine Risks and Costs
Registered attendees can view abstracts starting on 01/10/2019

Grays/Longs Peak
Jeffrey B. Ulmer, GSK Vaccines, USA
Molecular Approaches to Streamlining Vaccine Discovery and Development

Katalin Karikó, BioNTech RNA Pharmaceuticals, Germany
Advantages of an mRNA Vaccine Approach

Gary J. Nabel, Sanofi, USA
How Appropriate Choice of a Human Antibody Template Reduces Vaccine Development Risks

6:45—7:00 PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 01/10/2019

Grays/Longs Peak
6:45—7:00 PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 01/10/2019

Grays/Longs Peak
7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom
8:00—11:00 PM
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Colorado Rockies Ballroom

FRIDAY, FEBRUARY 15

 
Departure


*Session Chair †Invited, not yet responded.



We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



Keystone Symposia thanks our Sponsor for generously supporting this meeting:

BioLegend, Inc.

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



Viela Bio


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676